{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T02:10:17Z","timestamp":1792894217767,"version":"4.5.0"},"reference-count":132,"publisher":"Informa UK Limited","issue":"10","license":[{"start":{"date-parts":[[2021,9,18]],"date-time":"2021-09-18T00:00:00Z","timestamp":1631923200000},"content-version":"unspecified","delay-in-days":89,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"BeyondSpring Inc"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Anticancer Therapy"],"published-print":{"date-parts":[[2021,10,3]]},"DOI":"10.1080\/14737140.2021.1941891","type":"journal-article","created":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T06:01:56Z","timestamp":1623391316000},"page":"1145-1159","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":15,"title":["Prophylaxis and treatment strategies for optimizing chemotherapy relative dose intensity"],"prefix":"10.1080","volume":"21","author":[{"given":"Michelle","family":"Shayne","sequence":"first","affiliation":[{"name":"University of Rochester Medical Center, Rochester, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Donald","family":"Harvey","sequence":"additional","affiliation":[{"name":"Winship Cancer Institute and Emory University School of Medicine, Department of Hematology and Medical Oncology, Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0823-8086","authenticated-orcid":false,"given":"Gary H.","family":"Lyman","sequence":"additional","affiliation":[{"name":"Fred Hutchinson Cancer Research Center, The University of Washington, Seattle, WA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,6,21]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1986.4.8.1162"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2017.11.005"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1991.9.11.2042"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199504063321401"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.annonc.a058619"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.05.002"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.03.213"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.200"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-017-3692-x"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-013-2582-2"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2009.03.004"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2010.10.013"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25332"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1177\/1078155213492450"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-016-3421-x"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21847"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.2016.019588"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.05.645"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.08.8823"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt226"},{"issue":"10","key":"cit0021","first-page":"CD003039","volume":"2014","author":"Mhaskar R","journal-title":"Cochrane Database Syst Re"},{"key":"cit0022","unstructured":"Hematopoietic growth factors: version 2. 2021. National Comprehensive Cancer Network; [updated 2021 Mar 23; cited 2021 May 12]. Available from: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/growthfactors.pdf"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.62.3488"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmrv.2008.05.005"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1080\/14728214.2016.1184646"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-006-9254-4"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1186\/s40064-015-1165-6"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-014-2157-8"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-011-1949-5"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2015.1045894"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1159\/000148914"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)33137-4"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199405053301801"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.52.4785"},{"issue":"6","key":"cit0035","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1200\/JCO.2020.38.6_suppl.437","volume":"38","author":"Culine S","year":"2020","journal-title":"J Clin Oncol"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.53.2465"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2014.10.006"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.3109\/0284186X.2015.1054950"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2011.05.023"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.38314.622095.8F"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-018-1915-3"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2019.4668"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-017-4646-1"},{"key":"cit0044","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-015-1038-y"},{"key":"cit0045","first-page":"790186","volume":"2015","author":"Van Eeghen EE","year":"2015","journal-title":"Int Sch Res Notices"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004282"},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-010-0956-7"},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.234435"},{"key":"cit0049","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.2008"},{"key":"cit0050","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-020-03279-7"},{"key":"cit0051","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0123978"},{"key":"cit0052","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1991.9.3.499"},{"key":"cit0053","doi-asserted-by":"publisher","DOI":"10.1016\/j.clbc.2018.04.016"},{"key":"cit0054","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2017.04.001"},{"key":"cit0055","doi-asserted-by":"publisher","DOI":"10.1007\/s12029-014-9639-2"},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0707056"},{"key":"cit0057","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22939"},{"key":"cit0058","doi-asserted-by":"publisher","DOI":"10.3747\/co.v16i6.311"},{"key":"cit0059","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-019-05080-w"},{"key":"cit0060","unstructured":"Older adult oncology: verson 1. 2020 February 7. National Comprehensive Cancer Network; [updated 2020 Nov 10; cited 2020 Jan 5]. Available from: https:\/\/www.nccn.org\/about\/news\/ebulletin\/ebulletindetail.aspx?ebulletinid=1578"},{"key":"cit0061","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2015.0166"},{"key":"cit0062","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.39.9436"},{"key":"cit0063","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.11.1267"},{"key":"cit0064","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11544"},{"key":"cit0065","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.6687"},{"key":"cit0066","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.07.121"},{"key":"cit0067","doi-asserted-by":"publisher","DOI":"10.1080\/028418601750071082"},{"key":"cit0068","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-017-3842-1"},{"issue":"1","key":"cit0069","first-page":"19","volume":"42","author":"Awad M","year":"2017","journal-title":"P T"},{"key":"cit0070","unstructured":"Drug approval package: neulasta (pegfilgrastim) injection [Internet]: US Food & Drug Administration; 2002 [updated Jan 2002; cited 2020 Nov 16]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2002\/125031_0000_NeulastaTOC.cfm"},{"key":"cit0071","unstructured":"Biosimilar and Interchangeable Biologics: more treatment choices [Internet]: US Food and Drug Administration; 2020 [updated 2020 Mar 23; cited 2021 May 18]. Available from: https:\/\/www.fda.gov\/consumers\/consumer-updates\/biosimilar-and-interchangeable-biologics-more-treatment-choices"},{"key":"cit0072","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2017.23.12.1214"},{"key":"cit0073","volume-title":"Neupogen (filgrastim) prescribing information [Internet]","year":"2018"},{"key":"cit0074","unstructured":"Granix (tbo-filgrastim) prescribing information [Internet] North Wales, PA: cephalon; 2019 [updated Nov 2019; cited 2020 Oct 15]. Available from: https:\/\/www.granixhcp.com\/globalassets\/granix-hcp\/prescribing-information.pdf"},{"key":"cit0075","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2017.1386858"},{"key":"cit0076","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-015-3036-7"},{"key":"cit0077","doi-asserted-by":"publisher","DOI":"10.1080\/0284186X.2019.1670353"},{"key":"cit0078","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-015-2686-9"},{"key":"cit0079","unstructured":"Neulasta (pegfilgrastim) prescribing information [Internet]. Thousand Oaks, CA: Amgen; 2020;[updated Jan 2020; cited 2020 Oct 15]. Available from: https:\/\/www.pi.amgen.com\/~\/media\/amgen\/repositorysites\/pi-amgen-com\/neulasta\/neulasta_pi_hcp_english.pdf"},{"key":"cit0080","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-020-05295-2"},{"key":"cit0081","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2015.0014"},{"key":"cit0082","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2018.18094"},{"key":"cit0083","doi-asserted-by":"publisher","DOI":"10.1177\/1078155211407367"},{"key":"cit0084","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2017-0374"},{"key":"cit0085","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2017.1358173"},{"key":"cit0086","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw309"},{"key":"cit0087","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-015-2861-z"},{"key":"cit0088","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-018-4373-0"},{"key":"cit0089","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-017-3703-y"},{"key":"cit0090","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1G516"},{"key":"cit0091","doi-asserted-by":"publisher","DOI":"10.1111\/ecc.12043"},{"key":"cit0092","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2354.2008.00959.x"},{"key":"cit0093","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-13-11"},{"key":"cit0094","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.3227"},{"key":"cit0095","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2020.09.199"},{"key":"cit0096","volume":"25","author":"Schwartzberg LS","year":"2020","journal-title":"Oncologist"},{"key":"cit0097","volume-title":"Poster Presented at the Virtual San Antonio Breast Cancer Symposium","author":"Schwartzberg LS","year":"2020"},{"key":"cit0098","unstructured":"Clinicaltrials.gov. 2020. cited 2020 Dec 12]. Available from: https:\/\/clinicaltrials.gov\/"},{"key":"cit0099","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2019.07.95"},{"key":"cit0100","doi-asserted-by":"publisher","DOI":"10.1016\/j.cllc.2015.12.002"},{"key":"cit0101","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2019.10.61"},{"key":"cit0102","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2018.383"},{"key":"cit0103","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-015-2963-7"},{"key":"cit0104","unstructured":"Pegteograstim biological approved in South Korea [Internet]: 2014. updated September 19, 2014; cited 2020 Nov 19]. Available from: http:\/\/www.gabionline.net\/Biosimilars\/News\/Pegteograstim-biological-approved-in-South-Korea"},{"key":"cit0105","unstructured":"Evive Biotech meets primary and secondary endpoints in global phase III clinical trial for their novel chemotherapy-induced neutropenia treatment [Internet]: Evive Biotech; 2020 [updated 2020 Jul 7; cited 2020 Dec 14]. Available from: https:\/\/www.evivebiotech.com\/press_releases\/evive-biotech-meets-primary-and-secondary-endpoints-in-global-phase-iii-clinical-trial-for-their-novel-chemotherapy-induced-neutropenia-treatment\/"},{"key":"cit0106","volume-title":"2018 San Antonio Breast Cancer Symposium","author":"Glaspy J","year":"2018"},{"key":"cit0107","doi-asserted-by":"publisher","DOI":"10.1097\/01.cad.0000182745.01612.8a"},{"key":"cit0108","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2019.08.057"},{"key":"cit0109","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-12-323857"},{"key":"cit0110","doi-asserted-by":"publisher","DOI":"10.1111\/febs.13555"},{"key":"cit0111","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-019-03998-w"},{"key":"cit0112","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2020.4429"},{"key":"cit0113","unstructured":"BeyondSpring announces positive topline results from its PROTECTIVE-2 phase 3 registrational trial of plinabulin in combination with pegfilgrastim for prevention of chemotherapy-induced neutropenia [Internet]: BeyondSpring; 2020 [cited 2020 Dec 12]. Available from: https:\/\/www.beyondspringpharma.com\/pressreleases\/info.aspx?itemid=4239"},{"key":"cit0114","volume-title":"Poster Presented at the Virtual San Antonio Breast Cancer Symposium","author":"Blayney DW","year":"2020"},{"key":"cit0115","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-011-9642-4"},{"key":"cit0116","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aal3986"},{"key":"cit0117","author":"Daniel D","year":"2020","journal-title":"Int J Cancer"},{"key":"cit0118","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-020-01538-0"},{"key":"cit0119","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz278"},{"key":"cit0120","volume-title":"Presented at the 2020 Virtual Meeting of the San Antonio Breast Cancer Symposium","author":"O\u2019Shaughnessy J","year":"2020"},{"key":"cit0121","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30616-3"},{"key":"cit0122","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.12096"},{"key":"cit0123","unstructured":"FDA approves drug to reduce bone marrow suppression caused by chemotherapy [Internet]: U.S. Food & Drug Administration; 2021 [updated 2021 Feb 12; cited 2021 May 10]. Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-drug-reduce-bone-marrow-suppression-caused-chemotherapy"},{"key":"cit0124","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V124.21.4355.4355"},{"key":"cit0125","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2019.37.15_suppl.e23098"},{"key":"cit0126","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-114490"},{"key":"cit0127","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-018-0266-7"},{"issue":"13","key":"cit0128","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1158\/1538-7445.AM2019-360","volume":"79","author":"Kim Y-J","year":"2019","journal-title":"Cancer Re"},{"issue":"12","key":"cit0129","doi-asserted-by":"crossref","first-page":"A070","DOI":"10.1158\/1535-7163.TARG-19-A070","volume":"18","author":"Kim S-B","year":"2019","journal-title":"Mol Cancer Ther"},{"key":"cit0130","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.36.15_suppl.7043"},{"key":"cit0131","first-page":"1","author":"Griffiths EA","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"key":"cit0132","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2014.01.002"}],"container-title":["Expert Review of Anticancer Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737140.2021.1941891","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T14:26:16Z","timestamp":1672410376000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14737140.2021.1941891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,21]]},"references-count":132,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10,3]]}},"alternative-id":["10.1080\/14737140.2021.1941891"],"URL":"https:\/\/doi.org\/10.1080\/14737140.2021.1941891","relation":{},"ISSN":["1473-7140","1744-8328"],"issn-type":[{"value":"1473-7140","type":"print"},{"value":"1744-8328","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,21]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iery20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iery20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-04-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}